What are Lakewood-Amedex Biotherapeutics Inc. (LABT)'s total assets?

As of Dec 31, 2025, Lakewood-Amedex Biotherapeutics Inc. (LABT) reported total assets of $481,598. Source: the 10-Q filed with the SEC on May 22, 2026.

What are Lakewood-Amedex Biotherapeutics Inc. (LABT)'s total liabilities?

As of Dec 31, 2025, Lakewood-Amedex Biotherapeutics Inc. (LABT) reported total liabilities of $2.4 million. Source: the 10-Q filed with the SEC on May 22, 2026.

What are Lakewood-Amedex Biotherapeutics Inc. (LABT)'s cash and cash equivalents?

As of Dec 31, 2025, Lakewood-Amedex Biotherapeutics Inc. (LABT) reported cash and cash equivalents of $236,400. Source: the 10-Q filed with the SEC on May 22, 2026.

Lakewood-Amedex Biotherapeutics Inc.

LABT · XNAS

CIK 2079272fmd_1WN760Y4PMRNP0MY40G6R5D2RPManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2025 to Jun 30, 2026, 5 periods

Latest quarter · Q2 FY2026

Millions

Operating income: (4)
Net income: (4)

Daily close · LABTIEX trades only

Nov 09, 2026 to Nov 11, 2026 · 3 sessions

0.38 USD

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

Lakewood-Amedex Biotherapeutics Inc. (LABT) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

Metric	FY2025	Source
Total assets	$481,598	10-Q 2026-05-22 · proof
Total liabilities	$2.4 million	10-Q 2026-05-22 · proof
Cash and cash equivalents	$236,400	10-Q 2026-05-22 · proof

What are Lakewood-Amedex Biotherapeutics Inc. (LABT)'s total assets?: As of Dec 31, 2025, Lakewood-Amedex Biotherapeutics Inc. (LABT) reported total assets of $481,598. Source: the 10-Q filed with the SEC on May 22, 2026. SEC
What are Lakewood-Amedex Biotherapeutics Inc. (LABT)'s total liabilities?: As of Dec 31, 2025, Lakewood-Amedex Biotherapeutics Inc. (LABT) reported total liabilities of $2.4 million. Source: the 10-Q filed with the SEC on May 22, 2026. SEC
What are Lakewood-Amedex Biotherapeutics Inc. (LABT)'s cash and cash equivalents?: As of Dec 31, 2025, Lakewood-Amedex Biotherapeutics Inc. (LABT) reported cash and cash equivalents of $236,400. Source: the 10-Q filed with the SEC on May 22, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:LABT&period_type=annual&limit=5"

Information only, not investment advice.